SCHEMBL21030644

SCHEMBL21030644

c1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4c5ccccc5nc5sc6ccccc6c45)n3)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ ABCG2 Q9UNQ0 5/20 0.36
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ ATM Q13315 1/20 0.35
▸ CYP1A2 P05177 4/20 0.35
▸ CYP3A4 P08684 4/20 0.35
▸ CYP2C9 P11712 3/20 0.35
▸ CYP2C19 P33261 3/20 0.35
▸ CLK4 Q9HAZ1 3/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ USP2 O75604 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ ESR1 P03372 2/20 0.35
▸ ESR2 Q92731 2/20 0.35
▸ NR1I3 Q14994 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21031228 0.95 ADORA2A (0.36) ADORA2AADORA1ABCG2MEN1KMT2A
SCHEMBL21032054 0.94 MEN1 (0.37) ADORA2AADORA1ABCG2MEN1KMT2A
SCHEMBL21031451 0.94 MEN1 (0.37) ADORA2AADORA1ABCG2MEN1KMT2A
SCHEMBL21031449 0.94 MEN1 (0.37) ADORA2AADORA1ABCG2MEN1KMT2A
SCHEMBL25847663 0.94 MEN1 (0.37) ADORA2AADORA1ABCG2MEN1KMT2A
SCHEMBL25847664 0.94 ADORA2A (0.37) ADORA2AADORA1ABCG2MEN1KMT2A
SCHEMBL21031223 0.93 MEN1 (0.38) ADORA2AADORA1ABCG2MEN1KMT2A
SCHEMBL25847631 0.92 ADORA2A (0.38) ADORA2AADORA1ABCG2MEN1KMT2A
SCHEMBL23846047 0.92 MEN1 (0.41) ABCG2MEN1KMT2AATMCYP1A2
SCHEMBL21031440 0.92 MEN1 (0.41) ABCG2MEN1KMT2AATMCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 ADORA2A 2324/4885ADORA1 2991/4885ABCG2 114/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 ADORA2A 2324/4885ADORA1 2991/4885ABCG2 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback